GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Interest Expense

Willow Biosciences (TSX:WLLW) Interest Expense : C$-0.18 Mil (TTM As of Mar. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Willow Biosciences's interest expense for the three months ended in Mar. 2024 was C$ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Willow Biosciences's Operating Income for the three months ended in Mar. 2024 was C$ -2.46 Mil. Willow Biosciences's Interest Expense for the three months ended in Mar. 2024 was C$ -0.03 Mil. Willow Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Willow Biosciences Interest Expense Historical Data

The historical data trend for Willow Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Interest Expense Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.04 -0.03 -0.03 -0.14

Willow Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.14 -0.03

Willow Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Willow Biosciences  (TSX:WLLW) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Willow Biosciences's Interest Expense for the three months ended in Mar. 2024 was C$-0.03 Mil. Its Operating Income for the three months ended in Mar. 2024 was C$-2.46 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was C$1.36 Mil.

Willow Biosciences's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Willow Biosciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Willow Biosciences (TSX:WLLW) Business Description

Traded in Other Exchanges
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.
Executives
Patricia Ranija Choudhary Director

Willow Biosciences (TSX:WLLW) Headlines

No Headlines